Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery (LUNG ART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00410683

Recruitment Status : Unknown

Verified November 2020 by Gustave Roussy, Cancer Campus, Grand Paris.
Recruitment status was: Active, not recruiting

First Posted : December 13, 2006

Last Update Posted : November 20, 2020

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Intergroupe Francophone de Cancerologie Thoracique

The Christie NHS Foundation Trust

European Organisation for Research and Treatment of Cancer - EORTC

Information provided by (Responsible Party):

Gustave Roussy, Cancer Campus, Grand Paris

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Actual Primary Completion Date :	July 2018
Estimated Study Completion Date :	February 2022

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Erratum In: Lancet Oncol. 2022 Jul;23(7):e319.

To Top